Please select the option that best describes you:
Do you offer adjuvant chemotherapy to patients with urachal adenocarcinoma and at least one high risk feature?
e.g. lymph node metastasis, presence of tumor involving the peritoneal surfaces and/or the abdominal wall. If so, which regimen would you offer?
Answer from: Medical Oncologist at Academic Institution
In the absence of data in this space, I would offer adjuvant chemotherapy applying similar principles from colon adenocarcinoma for patients with T4 or node positive disease. FOLFOX/CAPOX for 3 to 6 months is reasonable in this situation. This regimen has the most reliable and reproducible data in t...
Sign in or Register to read more